ACS: Patients can be evaluated for stroke and trauma with STRAUMA Alert
Nov 03, 2021
While the approach adds a few minutes for time to CT, there was no impact on start of treatment
Parkinson disease mortality up in U.S. from 1999 to 2019
Oct 28, 2021
Increases seen across all age groups, both sexes, various racial/ethnic groups, different urban/rural classifications
More than half of personnel at LTCFs fully vaccinated for COVID-19
Jul 30, 2021
56.8 percent of HCP are fully vaccinated, with coverage higher for physicians and advanced practice providers than for nurses, aides
Shorter course of antibiotics noninferior for UTI in afebrile men
Jul 28, 2021
Seven days of antibiotics noninferior to 14-day course for resolution of symptoms among afebrile men with urinary tract infection
Heterogeneity identified in global kidney nutrition care
Jan 06, 2022
Dietitians and nephrologists only communicated sometimes on kidney nutrition care in 60 percent or more of countries
2012 to 2018 saw increase in opioid-linked cardiac arrest
Sep 03, 2021
Hospitalizations for cardiac arrest with opioid use linked to higher prevalence of alcohol, depression, and smoking
Intervention can cut risk for mobility disability in seniors
May 13, 2022
Reduced incidence of mobility disability is seen in older adults with physical frailty and sarcopenia receiving who receive a multicomponent intervention.
Mirtazapine does not reduce agitation in dementia patients
Nov 03, 2021
In randomized, double-blind trial, no difference seen in scores for agitated behaviors at 12 weeks with mirtazapine versus placebo
Abelacimab prevents VTE after total knee arthroplasty
Jul 26, 2021
Single, postoperative IV dose of abelacimab superior to enoxaparin for preventing venous thromboembolism, with no increase in bleeding risk
ADA: Efpeglenatide lowers risk for adverse CV events in T2DM
Jun 29, 2021
(HealthDay News) — For patients with type 2 diabetes and a history of cardiovascular disease or current kidney disease, the risk for adverse cardiovascular events is lower with efpeglenatide, an exendin-based...